Ultrafast slow-light tuning beyond the carrier lifetime using photonic crystal waveguides.

We demonstrate ultrafast delay tuning of a slow-light pulse with a response time <10 ps. This is achieved using two types of slow light: dispersion-compensated slow light for the signal pulse, and low-dispersion slow light to enhance nonlinear effects of the control pulse. These two types of slow light are generated simultaneously in Si lattice-shifted photonic crystal waveguides, arising from flat and straight photonic bands, respectively. The control pulse blueshifts the signal pulse spectrum, through dynamic tuning caused by the plasma effect of two-photon-absorption-induced carriers. This changes the delay by up to 10 ps only when the two pulses overlap within the waveguide and enables ultrafast tuning that is not limited by the carrier lifetime. Using this, we succeeded in tuning the delay of one target pulse within a pulse train with 12 ps intervals.

Predictive performance of equations to estimate creatinine clearance from serum creatinine in Japanese patients with congestive heart failure.

Seven methods using patient's age, weight, gender, and serum creatinine concentration were evaluated for mathematical and clinical predictive performance in estimating the creatinine clearance of Japanese patients. We compared the measured and estimated creatinine clearance in 179 hospitalized heart failure patients. The Gates equation was the most biased (mean prediction error, 17.9 mL/min), and the Yukawa equation was the most precise (mean absolute prediction error, 10.4 mL/min), followed by the Jelliffe, Bjornsson, Cockcroft and Gault, and Mawer equations. For all methods, precision was less when serum creatinine concentrations of <0.6 mg/dL were rounded than when serum creatinine concentrations of >/=0.6 mg/dL were rounded. We conclude that in clinical practice where the renal function can vary widely, any of the published formulas can give satisfactory results. The Yukawa formula is concise and gives better results in Japanese patients.

Simple and rapid high-performance liquid chromatography analysis of propentofylline and its main metabolites in serum using a direct injection technique.

A rapid, simple and reliable high-performance liquid chromatography (HPLC) column-switching method with UV detection (270 nm) for the simultaneous determination of propentofylline and its metabolites in human and rat sera was developed. The method involves direct injection of serum onto an HPLC column, which contains a shielded hydrophobic stationary phase for the separation of analytes from proteins in serum, and then loading the analytes onto a short octadecylsilylated silica gel (ODS) column using a switching valve. Propentofylline and its three metabolites in serum were separated from the serum components within 30 min after the injection. The detection limits (S/N = 3) of analytes spiked in human and rat sera ranged from 0.08 to 0.57 nmol/mL, and the net volume of serum used was 20 microL. The relative standard deviations for within- and between-day variations using rat serum were less than 4.3 and 5.6%, respectively. The method was used to determine propentofylline and its main metabolites in rat serum after a single intravenous dose of propentofylline (5 mg/kg).

High-performance liquid chromatography with peroxyoxalate chemiluminescence determination of propentofylline concentrations in rat brain microdialysate.

A high-performance liquid chromatographic determination of a neuronal cell protective compound, propentofylline [3-methyl-1-(5-oxohexyl)-7-propyl-7H-purine-2(3H),6(1H)-dione] was performed combining a microdialysis technique with peroxyoxalate chemiluminescence (PO-CL) detection. The microdialysate was subjected to a fluorescent derivatization of propentofylline with 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole (DBD-H) without further cleanup, because the membrane used in the microdialysis excluded high-molecular-mass proteins. The proposed method showed a good linearity in the determination range of 0.031 to 1.25 ng/injection; y (microV)=4234 x (ng)- 13.43, r=0.9993 (y=peak height and x=amount of propentofylline). The very low determination limit of 0.031 ng/injection was ca. 200 times more sensitive than that of HPLC-UV determination. The HPLC-PO-CL method was applied for the first time to determine propentofylline concentration in the dialysate obtained from the rat hippocampus after a single oral administration (25 mg/kg). Propentofylline showed its maximum extracellular fluid (ECF) concentration of 125.1+/-15.1 ng/ml (mean+/-SD, n=3) at 0.33 h after administration.

Use of 3-(1,8-naphthalimido)propyl-modified silyl silica gel as a stationary phase for the high-performance liquid chromatographic separation of purine derivatives.

The use of a packing material, 3-(1,8-naphthalimido)propyl-modified silyl silica gel (NAIP), as a stationary phase for high-performance liquid chromatography, has been studied. NAIP behaved like a reversed-phase stationary phase with some pi-pi interaction. Purine derivatives, i.e., xanthine, hypoxanthine, uric acid, theobromine, theophylline and caffeine, were separated by a column packed with NAIP using an eluent of borate solution (pH 6.4)-MeOH (50:50, v/v). Of these, caffeine was selected as the target of the subsequent investigation and its determination was examined in commercially available medicinal drinks and pharmaceutical preparations. The average recoveries of caffeine were 98.0-107.4% for five drinks and 99.6-107.8% for five tablets and one powder. Subsequently, determination of caffeine and its metabolites in human plasma was examined. In twelve normal human plasma, caffeine levels ranged from 0.24 to 4.26 micrograms/ml. Time curves of plasma caffeine concentrations and those of its demethylated metabolite, 1,7-dimethylxanthine (1,7-DMX), after an oral ingestion of caffeine (200 mg) were measured by the proposed method and it was found that the maximum concentrations of caffeine and 1,7-DMX were obtained at 1-1.5 h and 3-6 h after ingestion, respectively.

High-performance liquid chromatography with fluorescence detection of ebiratide using 4-(N,N-dimethylamino-sulphonyl)-7-fluoro-2,1,3-benzoxadiazole as a fluorogenic reagent.

A sensitive high-performance liquid chromatography (HPLC) method with fluorescence detection has been developed and applied to the determination of ACTH4-9 analogue (ebiratide). 4-(N,N-Dimethylamino-sulphonyl)-7-fluoro-2,1,3-benzoxadiazole (DBD-F) was used as a fluorogenic labelling reagent. Ebiratide in 0.1 M borate buffer (pH 9.0) was reacted with DBD-F in acetonitrile solution at 50 degrees C for 30 min. After cooling, the mixture was separated by a reversed-phase HPLC. Then DBD-ebiratide was monitored at 580 nm with the excitation at 440 nm. The calibration curve was linear up to 10 pmol on column (r = 0.999) with the detection limit of 0.25 pmol (signal-to-noise = 3).